ArticlePubMed 22
On December 22, 2025, the FDA approved the Wegovy pill (once-daily oral semaglutide 25 mg), marking the first time a GLP-1 receptor agonist has been cleared specifically for weight management in an oral form
Keep a symptom diary documenting when tiredness occurs, its severity, and any associated factors (meals, medication timing, activities)
First, in conjunction with combining data derived from several Swedish national registers, we obtained accurate information on prescription and the diagnosis of DR, as well as the other factors possibly related to the development and progression of DR
In combination with a healthy diet and exercise
Key factors include: Current body weight and muscle mass Age, especially over 60 Level of resistance training Rate of weight loss Kidney function Older adults often need the higher end of the range to protect against age-related muscle loss